Henshaw Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CCA
FAM
1WCM
Henshaw Capital's RGEN Position: Q3 2020 in Review
Henshaw Capital sold out of Repligen (RGEN) in Q3 2020, closing a stake of 2,130 shares — an estimated $263K sold.
Henshaw Capital first reported a position in RGEN in Q4 2018 and held it in 7 quarters. The position peaked at $412K in Q1 2020. 390 funds tracked by Wall St. Rank hold RGEN as of Q3 2020.
- Henshaw Capital reported no remaining Repligen position as of Q3 2020 after selling out during the quarter.
- Henshaw Capital sold 2,130 Repligen shares in Q3 2020, an estimated $263K.
- Henshaw Capital first reported a position in Repligen in Q4 2018 and held it in 7 quarters.
- Henshaw Capital's Repligen position peaked at $412K in Q1 2020.
- 390 funds tracked by Wall St. Rank held Repligen as of Q3 2020.
Based on Henshaw Capital's 13F filing for Q3 2020, filed 28 May 2026.